Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by alleyesonmeon Dec 18, 2021 9:58am
65 Views
Post# 34243233

RE:RE:Pfizer - Biontech - Dermapharm

RE:RE:Pfizer - Biontech - DermapharmThe world is realizing vaccines are not the solution treatment is. It is becoming evident effective treatment is cannabinoid based. Labs may not be the label of this treatment however their expertise in extraction will surely be called upon and needed to assist in worldwide supply. It's possible big things are happening behind the scenes since CEO's share purchase, big enough insiders are legally unable to purchase shares at historic lows until the developments are publicized. It's hard to believe Labs isn't a takeover target considering it's present valuation, licensing agreements, governmental certs, etc....speculative but I feel something massive is coming down the pipes.
<< Previous
Bullboard Posts
Next >>